Recurrence of chronic subdural hematoma due to low-grade infection.
MMA occlusion
chronic subdural hematoma
dexamethasone
infected subdural hematoma recurrence
recurrence
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
08
2022
accepted:
01
09
2022
entrez:
10
10
2022
pubmed:
11
10
2022
medline:
11
10
2022
Statut:
epublish
Résumé
Despite the high incidence and multitudes of operative techniques, the risk factors for chronic subdural hematoma (CSDH) recurrence are still under debate and a universal consensus on the pathophysiology is lacking. We hypothesized that clinically inapparent, a low-grade infection could be responsible for CSDH recurrence. This investigation is a single-center prospective observational study including patients with recurrent CSDH. In total, 44 patients with CSDH recurrence received an intraoperative swab-based microbiological test. The intraoperative swab revealed an inapparent low-grade hematoma infection in 29% of the recurrent CSDH cases. The majority (69%) of the identified germs belonged to the
Identifiants
pubmed: 36212639
doi: 10.3389/fneur.2022.1012255
pmc: PMC9539083
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1012255Informations de copyright
Copyright © 2022 Dubinski, Won, Trnovec, Gounko, Baumgarten, Warnke, Cantré, Behmanesh, Bernstock, Freiman, Gessler and Sola.
Déclaration de conflit d'intérêts
Author DD received financial support from Novartis, Fresenius, Inovitro, and Novocure. None of these entities were involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
World Neurosurg. 2022 Feb;158:84-99
pubmed: 34728401
J Neurotrauma. 2020 Dec 1;37(23):2493-2498
pubmed: 32458767
N Engl J Med. 2020 Dec 31;383(27):2616-2627
pubmed: 33326713
Neurosurgery. 2021 Jan 13;88(2):268-277
pubmed: 33026434
J Neurotrauma. 2014 Apr 1;31(7):670-3
pubmed: 24245657
Surg Neurol Int. 2021 Jun 14;12:288
pubmed: 34221619
No To Shinkei. 2002 Aug;54(8):703-6
pubmed: 12355883
BMC Infect Dis. 2020 May 19;20(1):357
pubmed: 32429864
J Neuroinflammation. 2017 May 30;14(1):108
pubmed: 28558815
Neurosurgery. 2020 Oct 15;87(5):964-970
pubmed: 32409827
Neurol Med Chir (Tokyo). 2014;54(5):363-73
pubmed: 24477064
No To Shinkei. 1997 Jan;49(1):81-4
pubmed: 9027908
Neurosurg Focus. 2017 Nov;43(5):E10
pubmed: 29088952
Neurosurg Clin N Am. 2017 Apr;28(2):205-210
pubmed: 28325454
Front Neurol. 2020 Aug 27;11:923
pubmed: 32973670
Neurosurgery. 1998 Jul;43(1):189-90
pubmed: 9657212
J Rural Med. 2018 May;13(1):86-88
pubmed: 29875903
World Neurosurg. 2016 Mar;87:663.e1-8
pubmed: 26585725
World Neurosurg. 2020 Sep;141:339-345
pubmed: 32593768
Front Surg. 2022 Feb 25;9:789118
pubmed: 35284472
J Trauma Acute Care Surg. 2021 Dec 1;91(6):e134-e141
pubmed: 34538825
Front Neurol. 2020 Nov 24;11:560269
pubmed: 33329304
World Neurosurg. 2017 Dec;108:948-953
pubmed: 28935548
Childs Nerv Syst. 2019 Apr;35(4):719-723
pubmed: 30446813